Programme highlight: lung cancer

Lung cancer remains the biggest cancer killer in Europe, accounting for approximately 20% of all cancer deaths. Yet, in recent years, several advances have been made in standards of care, personalised therapies, including immunotherapies and advances in diagnostics.

This year's Congress programme has a considerable variety of oncology-focussed activities including sessions, skills workshops, symposia, postgraduate courses, hot topic sessions, poster discussions, oral presentations, challenging clinical cases and meetings covering the most up-to-date developments in the field.

Chair of the ERS Thoracic Oncology Assembly Nicolas Schönfeld, highlighted: "The field of lung cancer is seeing several exciting changes that are leading the way in terms of treatments for all cancers. Immunotherapy developments are particularly exciting and a number of abstracts will be presented at the ERS Congress sharing the latest research in this field. I see this as a wonderful opportunity for not only assembly members, but all respiratory healthcare professionals interested in this field to learn what's new and where the next steps in targeted lung cancer therapies may take us."

Are you interested in joining the ERS Thoracic Oncology Assembly? You can do so on MyERS.

If you are interested in this topic, here is a list of associated sessions at this year's Congress. Alternatively, you can browse the full programme and filter your search by the 'Oncology' track for more sessions on this topic.

Note: Educational sessions (postgraduate courses, skills workshops, challenging clinical cases, professional development workshops and meet the expert sessions) can be attended at an additional cost to the standard registration fee.

Date Time Session Session type
03.09.16 09:30 to 13:00 PG7 New guidelines for the classification and staging of lung cancer Post-graduate course
03.09.16 09:30 to 13:00 PG5 How to reach peripheral solitary nodules Post-graduate course 
03.09.16 14:00 to 17:30 PG20 Thymic tumours Post-graduate course 
04.09.16 08:30 to 10:30 Immunotherapy: the lethal weapon against thoracic malignancies? Symposium
04.09.16 10:45 to 12:45 ERS-ALAT-SBPT-SEPAR-SPP joint session: Spanish and Portuguese Session II Session
04.09.16 10:45 to 12:45 Mesothelioma and pleural disease: from bench to bedside Oral presentation
04.09.16 10:45 to 12:45 Lung cancer and immune cells: friends or foes? Poster discussion
04.09.16 13:00 to 14:15 Assembly 11 Thoracic oncology: Incl. Groups 11.1 Lung cancer and 11.2 Pleural and mediastinal malignancies Assembly members' meeting
04.09.16 14:45 to 16:45 Is sleep apnoea causing cancer?: the evidence, limitations, and clinical perspectives Hot topic
04.09.16 14:45 to 16:45 Late-breaking translational research in lung cancer Oral presentation
05.09.16 07:00 to 08:15 CC4 Major challenges in thoracic surgical oncology Challenging clinical case
05.09.16 08:30 to 10:30 Lung cancer immunology: latest research Oral presentation 
05.09.16 10:45 to 12:45 Molecular footprints in lung cancer diagnosis and management Symposium
05.09.16 12:50 to 14:40 Epidemiology and specific subgroups in lung cancer Thematic poster 
05.09.16 12:50 to 14:40 Clinical aspects in lung cancer Thematic poster
05.09.16 12:50 to 14:40 Basic science and case reports in lung cancer Thematic poster 
05.09.16 12:50 to 14:40 Prognostic Parameters in lung cancer I Thematic poster 
05.09.16 12:50 to 14:40 Prognostic parameters in lung cancer II Thematic poster 
05.09.16 13:00 to 14:00 ME7 Surgery for lung cancer Meet the expert
05.09.16 13:30 to 14:30 Lung cancer: latest developments in screening and patient management: ERS/Lancet joint lunchtime Lunchtime session 
05.09.16 14:45 to 16:45 Updating on electronic nicotine delivery systems (ENDS) or e-cigarettes Symposium 
05.09.16 14:45 to 16:45 Scientific Grand Round: precision medicine: an interactive session Grand round 
05.09.16 14:45 to 16:45 Quality management and quality of life in lung cancer Poster discussion 
06.09.16 07:00 to 08:15 CC6 New treatment approaches in non-small cell lung cancer Challenging clinical cases
06.09.16 08:00 to 10:30 PD7 Designing and conducting research in malignant pleural effusion Professional development workshop
06.09.16 08:00 to 10:30 SW16 Radiological-pathological correlations for clinicians Skills workshop
06.09.16 08:00 to 10:30 Urban air pollution and human health Symposium
06.09.16 08:00 to 10:30 Malignant pleural disease: diagnosis and management Poster discussion
06.09.16 08:00 to 10:30 Therapeutic trials in lung cancer Oral presentation
06.09.16 10:40 to 13:00 SW18 Radiological-pathological correlations for clinicians Skills workshop
06.09.16 10:45 to 12:45 Endotyping: the means to personalised medicine in lung disease Symposium
06.09.16 10:45 to 12:45 Oligometastasis: postmodern multimodality concepts Symposium
06.09.16 10:45 to 12:45 Pulmonary endoscopy 2016: to freeze, heat, block or dig Year in review
06.09.16 10:45 to 12:45 The future is now: the aging challenge in respiratory medicine Hot topic
06.09.16 13:00 to 14:30 Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?: Pro/con discussions Lunchtime session
06.09.16 13:30 to 14:30 Should we start screening programmes in Europe: review of current scientific evidence Lunchtime session
06.09.16 14:30 to 16:50 SW20 Radiological-pathological correlations for clinicians Skills workshop
06.09.16 14:45 to 16:45 The future of tyrosin kinase inhibitors Symposium
 07.09.16  08:30 to 10:30 Extracellular vesicles in lung disease pathogenesis Symposium
07.09.16  08:30 to 10:30  Lung cancer: therapeutic modalities, re-staging and follow-up Poster discussion
07.09.16   10:45 to 12:45 The stage I non-small-cell lung cancer: What a pulmonologist and thoracic surgeon should know Symposium 
07.09.16  10:45 to 12:45  Mesothelioma and malignant pleural disease Poster discussion